| ASSET | QUARTER | % RETURN |
|---|---|---|
Eli Lilly and (LLY) | Q2 2022 | 13.69% |
Merck (MRK) | Q2 2022 | 11.83% |
International Business Machines (IBM) | Q2 2022 | 10.21% |
Exxon Mobil (XOM) | Q2 2022 | 5.52% |
Philip Morris International (PM) | Q2 2022 | 5.29% |
T-Mobile US (TMUS) | Q2 2022 | 4.32% |
Coca-Cola (KO) | Q2 2022 | 1.66% |
UnitedHealth (UNH) | Q2 2022 | 0.94% |
Johnson & Johnson (JNJ) | Q2 2022 | 0.9% |
AstraZeneca PLC ADR (AZN) | Q2 2022 | 0.52% |
McDonald’s (MCD) | Q2 2022 | 0.05% |
PepsiCo (PEP) | Q2 2022 | -0.04% |
Novo Nordisk A-S (NVO) | Q2 2022 | -0.12% |
Novartis AG ADR (NVS) | Q2 2022 | -3.05% |
Shell PLC ADR (SHEL) | Q2 2022 | -4.02% |
AbbVie (ABBV) | Q2 2022 | -4.74% |
Procter & Gamble (PG) | Q2 2022 | -5.81% |
Home Depot (HD) | Q2 2022 | -8.15% |
Abbott Laboratories (ABT) | Q2 2022 | -8.21% |
LIN TV (LIN) | Q2 2022 | -10.07% |
Chevron (CVX) | Q2 2022 | -10.33% |
Visa Inc Class A (V) | Q2 2022 | -11.57% |
Mastercard (MA) | Q2 2022 | -12.05% |
Morgan Stanley (MS) | Q2 2022 | -12.96% |
ServiceNow (NOW) | Q2 2022 | -14.49% |
Mega-cap stocks are treated as having a market cap of $200B+.
